Jay Parrish, Chief Business Officer at Vir Biotechnology, Inc. (VIR), sold 13,886 shares at $39.15 ($544K) on 2020-09-01, disclosed to the SEC on 2020-09-03.
Open-market sale of $544k VIR by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.15 | 6,943 | $272K | 50.0% |
| 2 | $39.15 | 6,943 | $272K | 50.0% |
| Total | $39.15 avg | 13,886 | $544K | 100% |
| Filing → |
| VIR | SELL | 2021-02-02 | $971K | — | Filing → |
| VIR | SELL | 2021-01-05 | $366K | — | Filing → |
| VIR | SELL | 2020-12-02 | $438K | — | Filing → |